We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Introduces One-Stop Chemiluminescence Immunoassay Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022
Print article
Image: Fapon is displaying its extensive IVD product portfolio at MEDICA 2022 (Photo courtesy of Fapon)
Image: Fapon is displaying its extensive IVD product portfolio at MEDICA 2022 (Photo courtesy of Fapon)

Fapon Biotech Inc. (Dongguan, China) is displaying its extensive IVD product portfolio at MEDICA 2022 comprising of core IVD raw materials for immunoassays and molecular diagnostics, including 1300+ antibodies, antigens, enzymes, blockers, etc.; reagent services for comprehensive disease testing; open instrument platforms for chemiluminescence Immunoassay (CLIA) and molecular diagnostics; and its one-stop solution for CLIA.

At this year’s edition of MEDICA, Fapon is exhibiting the Shine i1000 fully automatic and simple-to-use benchtop CLIA analyzer which has a throughput of 120 tests per hour and provides the first result in less than 15 minutes. Shine i1000 combines incubation, washing and detection in an all-in-one innovative design and its small size with a weight of less than 38 kg makes it ideal for different settings. Fapon is also displaying the Shine i2000 fully automatic CLIA analyzer which has a throughput of up to 200 tests per hour and takes 10-15 minutes to deliver the first result. Shine i2000 has a built-in 10-12 point calibration curve with 2-3 point verification and offers convenience with a three hour walk away capacity.

Alongside the CLIA analyzers, Fapon’s rapid molecular diagnostic systems, the P810 and iCatch 2000, are also on display at MEDICA 2022. The P810 is a real-time fluorescence quantitative PCR analyzer that is designed for scientific research and medical applications which integrates nucleic acid amplification, result analysis and report delivery. iCatch 2000 is a fully automatic nucleic acid analyzer which can realize sample-to-answer automation within 30 minutes. In addition, is highlighting its raw materials and reagent solutions for both immunoassay and molecular diagnostics platforms, such as cardiac markers, tumor markers, respiratory disease, inflammatory markers, tropical diseases, infectious diseases, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, etc.

Related Links:
Fapon Biotech Inc

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.